비교리스트

 카트 문의
시장보고서
상품코드
1655521

세계의 무표지 어레이 시스템 시장

Label-free Array Systems
발행일: | 리서치사: Global Industry Analysts, Inc. | 페이지 정보: 영문 193 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계 무표지 어레이 시스템 시장은 2030년까지 24억 달러에 이를 전망

2024년에 18억 달러에 이른 것으로 추정되는 무표지 어레이 시스템 세계 시장은 2030년에는 24억 달러에 이르고, 분석 기간인 2024-2030년간 CAGR 5.6%로 성장할 것으로 예측됩니다. 본 보고서에서 분석한 부문 중 하나인 표면 프라즈몬 공명(SPR) 기술은 CAGR 5.8%를 나타내고, 분석 기간 종료까지 18억 달러에 이를 것으로 예측됩니다. 생체층 간섭법(Bio-layer Interferometry : BLI) 기술 부문의 성장률은 분석 기간 CAGR 5.1%로 추정됩니다.

미국 시장은 4억 8,430만 달러, 중국은 CAGR 5.3%로 성장 예측

미국의 무표지 어레이 시스템 시장은 2024년에 4억 8,430만 달러에 이른 것으로 추정됩니다. 세계 2위 경제대국인 중국은 분석 기간인 2024-2030년간 CAGR 5.3%로 성장하여 2030년까지 3억 8,280만 달러 규모에 이를 것으로 예측됩니다. 기타 주목해야 할 지역별 시장으로서는 일본과 캐나다가 있으며, 분석 기간중 CAGR은 각각 5.3%와 4.7%를 나타낼 것으로 예측됩니다. 유럽에서는 독일이 CAGR 5.2%로 성장할 것으로 예측됩니다.

세계의 무표지 어레이 시스템 시장 - 주요 동향과 성장 촉진요인 정리

무표지 어레이 시스템은 생의학 연구를 어떻게 변화시키고 있는가?

무표지 어레이 시스템은 형광 표지나 방사성 표지 없이도 생체 분자의 상호작용을 실시간으로 비침습적으로 분석할 수 있어 생의학 연구에 매우 유용한 도구가 되고 있습니다. 이러한 시스템을 통해 과학자들은 세포 반응, 단백질 상호작용, 질병 경로를 보다 자연스럽게 연구할 수 있으며, 신약 개발, 진단, 바이오마커 식별에 특히 유용합니다. 무표지 기술은 분자간 상호작용에 대한 통찰력을 제공함으로써 보다 빠르고 정확한 데이터 수집을 지원하고, 연구 방법의 효율성을 높이며, 새로운 치료법 개발을 가속화할 수 있습니다.

신약개발에 있어 무라벨 기술의 장점은 무엇인가?

신약 개발에서 제약 연구자들은 라벨에 의한 분자 거동 변화의 위험을 최소화하면서 잠재적인 약물 상호 작용을 직접 조사할 수 있습니다. 결합 친화도, 동력학적 프로파일, 세포 반응을 실시간으로 모니터링할 수 있어 약물 스크리닝 과정의 정확성을 향상시키고, 유망한 화합물을 조기에 식별할 수 있습니다. 또한, 라벨이 없는 시스템은 라벨 기반 분석과 관련된 비용과 시간을 줄여 보다 효율적이고 비용 효율적인 신약 개발 파이프라인을 지원합니다. 이러한 정확성과 효율성으로 인해 무표지 어레이 시스템은 현대 제약 연구에서 선호되는 접근법이 되었습니다.

기술의 발전은 라벨 프리 시스템을 어떻게 개선하고 있는가?

최근 표면 플라즈몬 공명(SPR), 생체층 간섭법(BLI) 등의 검출법의 발전은 무표지 어레이 시스템의 민감도와 범용성을 높이고 있습니다. 이러한 기술은 더 작은 규모에서 더 정밀한 분석을 가능하게 하고, 저농도의 생체분자 검출과 복잡한 시료의 분석을 가능하게 합니다. 자동화와 데이터 분석과의 통합을 통해 처리량을 더욱 향상시켜 대규모 연구를 위한 하이스루풋 스크리닝을 가능하게 합니다. 이러한 검출 및 분석의 향상으로 라벨 프리 시스템의 용도가 확대되고 연구 및 임상 현장에서의 가치가 높아지고 있습니다.

무표지 어레이 시스템 시장의 성장은 몇 가지 요인으로 인해 발생합니다.

무라벨 어레이 시스템 시장의 성장은 정확하고 처리량이 높은 신약 개발 툴에 대한 수요, 검출 기술의 발전, 효율적인 생체 분자 분석의 필요성 등 여러 요인에 의해 주도되고 있습니다. 제약회사와 생명공학 기업들이 신약 스크리닝을 위한 보다 정밀한 툴을 요구하고 있는 가운데, 무라벨 시스템은 속도와 정확성에서 우위를 점하고 있습니다. 시스템의 민감도를 높이고 실시간 모니터링을 가능하게 하는 기술 개발도 시장의 가능성을 넓히고 있습니다. 또한, 효과적인 진단 도구와 바이오마커 탐색 도구의 필요성이 생명과학 연구에서 중요한 장비로 자리매김하면서 무표지 어레이 시스템 수요가 증가하고 있습니다.

부문

응용 분야(신약 개발, 항체 특성화 및 개발, 단백질 인터페이스 분석, 단백질 복합체 및 캐스케이드 분석); 최종 용도(R&D 연구소, 임상시험수탁기관(CRO), 농업 연구 기관, 기타 최종 용도); 기술(표면 플라즈몬 공명(SPR), 생물층 간섭 측정(BLI), 세포 유전체 분광법(CDS), 석영 크리스탈 마이크로밸런스)

조사 대상 기업 예(43개사)

  • Agilent Technologies, Inc.
  • Attana AB
  • Bio-Rad Laboratories, Inc.
  • F. Hoffmann-La Roche AG
  • ForteBio
  • GWC Technologies
  • Molecular Devices LLC
  • PerkinElmer, Inc.
  • Riot Blockchain, Inc.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 기타 유럽
  • 아시아태평양
  • 기타 지역

제4장 경쟁

LSH 25.03.13

Global Label-free Array Systems Market to Reach US$2.4 Billion by 2030

The global market for Label-free Array Systems estimated at US$1.8 Billion in the year 2024, is expected to reach US$2.4 Billion by 2030, growing at a CAGR of 5.6% over the analysis period 2024-2030. Surface Plasmon Resonance (SPR) Technology, one of the segments analyzed in the report, is expected to record a 5.8% CAGR and reach US$1.8 Billion by the end of the analysis period. Growth in the Bio-layer Interferometry (BLI) Technology segment is estimated at 5.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$484.3 Million While China is Forecast to Grow at 5.3% CAGR

The Label-free Array Systems market in the U.S. is estimated at US$484.3 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$382.8 Million by the year 2030 trailing a CAGR of 5.3% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 5.3% and 4.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.2% CAGR.

Global Label-Free Array Systems Market - Key Trends & Drivers Summarized

How Are Label-Free Array Systems Transforming Biomedical Research?

Label-free array systems have become invaluable tools in biomedical research, offering real-time, non-invasive analysis of biomolecular interactions without the need for fluorescent or radioactive labels. These systems allow scientists to study cell responses, protein interactions, and disease pathways more naturally, making them particularly useful for drug discovery, diagnostics, and biomarker identification. By providing insights into molecular interactions in their native states, label-free technologies support faster, more accurate data collection, enhancing the efficiency of research processes and accelerating the development of new therapeutics.

What Are the Advantages of Label-Free Technology for Drug Discovery?

In drug discovery, label-free array systems enable pharmaceutical researchers to study potential drug interactions directly, minimizing the risk of altering molecular behavior through labeling. This ability to monitor binding affinities, kinetic profiles, and cellular responses in real time improves the accuracy of drug screening processes, making it easier to identify promising compounds in early stages. Additionally, label-free systems reduce costs and time associated with label-based assays, supporting more efficient and cost-effective drug discovery pipelines. This precision and efficiency make label-free array systems a favored approach in modern pharmaceutical research.

How Are Technological Advances Improving Label-Free Systems?

Recent advancements in detection methods, such as surface plasmon resonance (SPR) and bio-layer interferometry (BLI), are enhancing the sensitivity and versatility of label-free array systems. These technologies allow for more refined analysis at smaller scales, making it possible to detect low-abundance biomolecules and analyze complex samples. Automation and integration with data analytics further improve throughput, enabling high-throughput screening for large-scale studies. These improvements in detection and analysis are expanding the applications of label-free systems, increasing their value in research and clinical settings.

The Growth in the Label-Free Array Systems Market Is Driven by Several Factors

The growth in the label-free array systems market is driven by several factors, including the demand for accurate, high-throughput drug discovery tools, advancements in detection technology, and the need for efficient biomolecular analysis. As pharmaceutical and biotech companies seek more precise tools for drug screening, label-free systems offer advantages in speed and accuracy. Technological developments that enhance system sensitivity and allow for real-time monitoring are also expanding market potential. Additionally, the need for effective diagnostic and biomarker discovery tools is bolstering demand for label-free array systems, positioning them as critical instruments in life sciences research.

SCOPE OF STUDY:

The report analyzes the Label-free Array Systems market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Application (Drug Discovery, Antibody Characterization and Development, Protein Interface Analysis, Protein Complex and Cascade Analysis); End-Use (R&D Laboratories, Contract Research Organizations (CROs), Agriculture Research Institutes, Other End-Uses); Technology (Surface Plasmon Resonance (SPR), Bio-layer Interferometry (BLI), Cellular Dielectric Spectroscopy (CDS), Quartz Crystal Microbalance)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 43 Featured) -

  • Agilent Technologies, Inc.
  • Attana AB
  • Bio-Rad Laboratories, Inc.
  • F. Hoffmann-La Roche AG
  • ForteBio
  • GWC Technologies
  • Molecular Devices LLC
  • PerkinElmer, Inc.
  • Riot Blockchain, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Impact of Covid-19 and a Looming Global Recession
    • Label-free Array Systems - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Growing Demand for Non-Invasive Biomolecular Analysis
    • Increasing Adoption in Drug Discovery and Development
    • Technological Advancements Enhancing System Sensitivity and Accuracy
    • Demand for Real-Time Analysis in Biomedical Research
    • Rise in Precision Medicine Applications for Label-Free Technologies
    • Growth in Research Funding for Biotechnology and Pharmaceutical Sectors
    • Adoption of Label-Free Systems for High-Throughput Screening
    • Demand for Rapid Diagnostics and Biomarker Identification Solutions
    • Expanding Use in Cancer Research for Accurate Molecular Profiling
    • Increased Use in Studying Protein-Protein and Protein-DNA Interactions
    • Technological Integration with AI for Enhanced Data Analysis
    • Rising Demand for Efficient Research Tools in Academic Institutions
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Label-free Array Systems Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Label-free Array Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Label-free Array Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Label-free Array Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Surface Plasmon Resonance (SPR) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Surface Plasmon Resonance (SPR) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Surface Plasmon Resonance (SPR) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Bio-layer Interferometry (BLI) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Bio-layer Interferometry (BLI) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Bio-layer Interferometry (BLI) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Cellular Dielectric Spectroscopy (CDS) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Cellular Dielectric Spectroscopy (CDS) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Cellular Dielectric Spectroscopy (CDS) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Quartz Crystal Microbalance by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Quartz Crystal Microbalance by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Quartz Crystal Microbalance by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Drug Discovery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Drug Discovery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Drug Discovery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Antibody Characterization and Development by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Antibody Characterization and Development by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Antibody Characterization and Development by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Protein Interface Analysis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Protein Interface Analysis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Protein Interface Analysis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Protein Complex and Cascade Analysis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Protein Complex and Cascade Analysis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Protein Complex and Cascade Analysis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for R&D Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for R&D Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for R&D Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Contract Research Organizations (CROs) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Contract Research Organizations (CROs) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for Contract Research Organizations (CROs) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Agriculture Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Agriculture Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: World 15-Year Perspective for Agriculture Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 38: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 39: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Label-free Array Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 41: USA Recent Past, Current & Future Analysis for Label-free Array Systems by Technology - Surface Plasmon Resonance (SPR), Bio-layer Interferometry (BLI), Cellular Dielectric Spectroscopy (CDS) and Quartz Crystal Microbalance - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Label-free Array Systems by Technology - Surface Plasmon Resonance (SPR), Bio-layer Interferometry (BLI), Cellular Dielectric Spectroscopy (CDS) and Quartz Crystal Microbalance Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: USA 15-Year Perspective for Label-free Array Systems by Technology - Percentage Breakdown of Value Sales for Surface Plasmon Resonance (SPR), Bio-layer Interferometry (BLI), Cellular Dielectric Spectroscopy (CDS) and Quartz Crystal Microbalance for the Years 2015, 2025 & 2030
    • TABLE 44: USA Recent Past, Current & Future Analysis for Label-free Array Systems by Application - Drug Discovery, Antibody Characterization and Development, Protein Interface Analysis and Protein Complex and Cascade Analysis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: USA Historic Review for Label-free Array Systems by Application - Drug Discovery, Antibody Characterization and Development, Protein Interface Analysis and Protein Complex and Cascade Analysis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: USA 15-Year Perspective for Label-free Array Systems by Application - Percentage Breakdown of Value Sales for Drug Discovery, Antibody Characterization and Development, Protein Interface Analysis and Protein Complex and Cascade Analysis for the Years 2015, 2025 & 2030
    • TABLE 47: USA Recent Past, Current & Future Analysis for Label-free Array Systems by End-Use - R&D Laboratories, Contract Research Organizations (CROs), Agriculture Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: USA Historic Review for Label-free Array Systems by End-Use - R&D Laboratories, Contract Research Organizations (CROs), Agriculture Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: USA 15-Year Perspective for Label-free Array Systems by End-Use - Percentage Breakdown of Value Sales for R&D Laboratories, Contract Research Organizations (CROs), Agriculture Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Label-free Array Systems by Technology - Surface Plasmon Resonance (SPR), Bio-layer Interferometry (BLI), Cellular Dielectric Spectroscopy (CDS) and Quartz Crystal Microbalance - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Label-free Array Systems by Technology - Surface Plasmon Resonance (SPR), Bio-layer Interferometry (BLI), Cellular Dielectric Spectroscopy (CDS) and Quartz Crystal Microbalance Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Canada 15-Year Perspective for Label-free Array Systems by Technology - Percentage Breakdown of Value Sales for Surface Plasmon Resonance (SPR), Bio-layer Interferometry (BLI), Cellular Dielectric Spectroscopy (CDS) and Quartz Crystal Microbalance for the Years 2015, 2025 & 2030
    • TABLE 53: Canada Recent Past, Current & Future Analysis for Label-free Array Systems by Application - Drug Discovery, Antibody Characterization and Development, Protein Interface Analysis and Protein Complex and Cascade Analysis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Canada Historic Review for Label-free Array Systems by Application - Drug Discovery, Antibody Characterization and Development, Protein Interface Analysis and Protein Complex and Cascade Analysis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Canada 15-Year Perspective for Label-free Array Systems by Application - Percentage Breakdown of Value Sales for Drug Discovery, Antibody Characterization and Development, Protein Interface Analysis and Protein Complex and Cascade Analysis for the Years 2015, 2025 & 2030
    • TABLE 56: Canada Recent Past, Current & Future Analysis for Label-free Array Systems by End-Use - R&D Laboratories, Contract Research Organizations (CROs), Agriculture Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Canada Historic Review for Label-free Array Systems by End-Use - R&D Laboratories, Contract Research Organizations (CROs), Agriculture Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: Canada 15-Year Perspective for Label-free Array Systems by End-Use - Percentage Breakdown of Value Sales for R&D Laboratories, Contract Research Organizations (CROs), Agriculture Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • JAPAN
    • Label-free Array Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 59: Japan Recent Past, Current & Future Analysis for Label-free Array Systems by Technology - Surface Plasmon Resonance (SPR), Bio-layer Interferometry (BLI), Cellular Dielectric Spectroscopy (CDS) and Quartz Crystal Microbalance - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for Label-free Array Systems by Technology - Surface Plasmon Resonance (SPR), Bio-layer Interferometry (BLI), Cellular Dielectric Spectroscopy (CDS) and Quartz Crystal Microbalance Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: Japan 15-Year Perspective for Label-free Array Systems by Technology - Percentage Breakdown of Value Sales for Surface Plasmon Resonance (SPR), Bio-layer Interferometry (BLI), Cellular Dielectric Spectroscopy (CDS) and Quartz Crystal Microbalance for the Years 2015, 2025 & 2030
    • TABLE 62: Japan Recent Past, Current & Future Analysis for Label-free Array Systems by Application - Drug Discovery, Antibody Characterization and Development, Protein Interface Analysis and Protein Complex and Cascade Analysis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Japan Historic Review for Label-free Array Systems by Application - Drug Discovery, Antibody Characterization and Development, Protein Interface Analysis and Protein Complex and Cascade Analysis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: Japan 15-Year Perspective for Label-free Array Systems by Application - Percentage Breakdown of Value Sales for Drug Discovery, Antibody Characterization and Development, Protein Interface Analysis and Protein Complex and Cascade Analysis for the Years 2015, 2025 & 2030
    • TABLE 65: Japan Recent Past, Current & Future Analysis for Label-free Array Systems by End-Use - R&D Laboratories, Contract Research Organizations (CROs), Agriculture Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Japan Historic Review for Label-free Array Systems by End-Use - R&D Laboratories, Contract Research Organizations (CROs), Agriculture Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: Japan 15-Year Perspective for Label-free Array Systems by End-Use - Percentage Breakdown of Value Sales for R&D Laboratories, Contract Research Organizations (CROs), Agriculture Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • CHINA
    • Label-free Array Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 68: China Recent Past, Current & Future Analysis for Label-free Array Systems by Technology - Surface Plasmon Resonance (SPR), Bio-layer Interferometry (BLI), Cellular Dielectric Spectroscopy (CDS) and Quartz Crystal Microbalance - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: China Historic Review for Label-free Array Systems by Technology - Surface Plasmon Resonance (SPR), Bio-layer Interferometry (BLI), Cellular Dielectric Spectroscopy (CDS) and Quartz Crystal Microbalance Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: China 15-Year Perspective for Label-free Array Systems by Technology - Percentage Breakdown of Value Sales for Surface Plasmon Resonance (SPR), Bio-layer Interferometry (BLI), Cellular Dielectric Spectroscopy (CDS) and Quartz Crystal Microbalance for the Years 2015, 2025 & 2030
    • TABLE 71: China Recent Past, Current & Future Analysis for Label-free Array Systems by Application - Drug Discovery, Antibody Characterization and Development, Protein Interface Analysis and Protein Complex and Cascade Analysis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: China Historic Review for Label-free Array Systems by Application - Drug Discovery, Antibody Characterization and Development, Protein Interface Analysis and Protein Complex and Cascade Analysis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: China 15-Year Perspective for Label-free Array Systems by Application - Percentage Breakdown of Value Sales for Drug Discovery, Antibody Characterization and Development, Protein Interface Analysis and Protein Complex and Cascade Analysis for the Years 2015, 2025 & 2030
    • TABLE 74: China Recent Past, Current & Future Analysis for Label-free Array Systems by End-Use - R&D Laboratories, Contract Research Organizations (CROs), Agriculture Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: China Historic Review for Label-free Array Systems by End-Use - R&D Laboratories, Contract Research Organizations (CROs), Agriculture Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: China 15-Year Perspective for Label-free Array Systems by End-Use - Percentage Breakdown of Value Sales for R&D Laboratories, Contract Research Organizations (CROs), Agriculture Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • EUROPE
    • Label-free Array Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Label-free Array Systems by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Label-free Array Systems by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: Europe 15-Year Perspective for Label-free Array Systems by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Label-free Array Systems by Technology - Surface Plasmon Resonance (SPR), Bio-layer Interferometry (BLI), Cellular Dielectric Spectroscopy (CDS) and Quartz Crystal Microbalance - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for Label-free Array Systems by Technology - Surface Plasmon Resonance (SPR), Bio-layer Interferometry (BLI), Cellular Dielectric Spectroscopy (CDS) and Quartz Crystal Microbalance Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: Europe 15-Year Perspective for Label-free Array Systems by Technology - Percentage Breakdown of Value Sales for Surface Plasmon Resonance (SPR), Bio-layer Interferometry (BLI), Cellular Dielectric Spectroscopy (CDS) and Quartz Crystal Microbalance for the Years 2015, 2025 & 2030
    • TABLE 83: Europe Recent Past, Current & Future Analysis for Label-free Array Systems by Application - Drug Discovery, Antibody Characterization and Development, Protein Interface Analysis and Protein Complex and Cascade Analysis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Europe Historic Review for Label-free Array Systems by Application - Drug Discovery, Antibody Characterization and Development, Protein Interface Analysis and Protein Complex and Cascade Analysis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: Europe 15-Year Perspective for Label-free Array Systems by Application - Percentage Breakdown of Value Sales for Drug Discovery, Antibody Characterization and Development, Protein Interface Analysis and Protein Complex and Cascade Analysis for the Years 2015, 2025 & 2030
    • TABLE 86: Europe Recent Past, Current & Future Analysis for Label-free Array Systems by End-Use - R&D Laboratories, Contract Research Organizations (CROs), Agriculture Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Europe Historic Review for Label-free Array Systems by End-Use - R&D Laboratories, Contract Research Organizations (CROs), Agriculture Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: Europe 15-Year Perspective for Label-free Array Systems by End-Use - Percentage Breakdown of Value Sales for R&D Laboratories, Contract Research Organizations (CROs), Agriculture Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • FRANCE
    • Label-free Array Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 89: France Recent Past, Current & Future Analysis for Label-free Array Systems by Technology - Surface Plasmon Resonance (SPR), Bio-layer Interferometry (BLI), Cellular Dielectric Spectroscopy (CDS) and Quartz Crystal Microbalance - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: France Historic Review for Label-free Array Systems by Technology - Surface Plasmon Resonance (SPR), Bio-layer Interferometry (BLI), Cellular Dielectric Spectroscopy (CDS) and Quartz Crystal Microbalance Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: France 15-Year Perspective for Label-free Array Systems by Technology - Percentage Breakdown of Value Sales for Surface Plasmon Resonance (SPR), Bio-layer Interferometry (BLI), Cellular Dielectric Spectroscopy (CDS) and Quartz Crystal Microbalance for the Years 2015, 2025 & 2030
    • TABLE 92: France Recent Past, Current & Future Analysis for Label-free Array Systems by Application - Drug Discovery, Antibody Characterization and Development, Protein Interface Analysis and Protein Complex and Cascade Analysis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: France Historic Review for Label-free Array Systems by Application - Drug Discovery, Antibody Characterization and Development, Protein Interface Analysis and Protein Complex and Cascade Analysis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: France 15-Year Perspective for Label-free Array Systems by Application - Percentage Breakdown of Value Sales for Drug Discovery, Antibody Characterization and Development, Protein Interface Analysis and Protein Complex and Cascade Analysis for the Years 2015, 2025 & 2030
    • TABLE 95: France Recent Past, Current & Future Analysis for Label-free Array Systems by End-Use - R&D Laboratories, Contract Research Organizations (CROs), Agriculture Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: France Historic Review for Label-free Array Systems by End-Use - R&D Laboratories, Contract Research Organizations (CROs), Agriculture Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: France 15-Year Perspective for Label-free Array Systems by End-Use - Percentage Breakdown of Value Sales for R&D Laboratories, Contract Research Organizations (CROs), Agriculture Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • GERMANY
    • Label-free Array Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 98: Germany Recent Past, Current & Future Analysis for Label-free Array Systems by Technology - Surface Plasmon Resonance (SPR), Bio-layer Interferometry (BLI), Cellular Dielectric Spectroscopy (CDS) and Quartz Crystal Microbalance - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Germany Historic Review for Label-free Array Systems by Technology - Surface Plasmon Resonance (SPR), Bio-layer Interferometry (BLI), Cellular Dielectric Spectroscopy (CDS) and Quartz Crystal Microbalance Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Germany 15-Year Perspective for Label-free Array Systems by Technology - Percentage Breakdown of Value Sales for Surface Plasmon Resonance (SPR), Bio-layer Interferometry (BLI), Cellular Dielectric Spectroscopy (CDS) and Quartz Crystal Microbalance for the Years 2015, 2025 & 2030
    • TABLE 101: Germany Recent Past, Current & Future Analysis for Label-free Array Systems by Application - Drug Discovery, Antibody Characterization and Development, Protein Interface Analysis and Protein Complex and Cascade Analysis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Germany Historic Review for Label-free Array Systems by Application - Drug Discovery, Antibody Characterization and Development, Protein Interface Analysis and Protein Complex and Cascade Analysis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Germany 15-Year Perspective for Label-free Array Systems by Application - Percentage Breakdown of Value Sales for Drug Discovery, Antibody Characterization and Development, Protein Interface Analysis and Protein Complex and Cascade Analysis for the Years 2015, 2025 & 2030
    • TABLE 104: Germany Recent Past, Current & Future Analysis for Label-free Array Systems by End-Use - R&D Laboratories, Contract Research Organizations (CROs), Agriculture Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Germany Historic Review for Label-free Array Systems by End-Use - R&D Laboratories, Contract Research Organizations (CROs), Agriculture Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: Germany 15-Year Perspective for Label-free Array Systems by End-Use - Percentage Breakdown of Value Sales for R&D Laboratories, Contract Research Organizations (CROs), Agriculture Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 107: Italy Recent Past, Current & Future Analysis for Label-free Array Systems by Technology - Surface Plasmon Resonance (SPR), Bio-layer Interferometry (BLI), Cellular Dielectric Spectroscopy (CDS) and Quartz Crystal Microbalance - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Italy Historic Review for Label-free Array Systems by Technology - Surface Plasmon Resonance (SPR), Bio-layer Interferometry (BLI), Cellular Dielectric Spectroscopy (CDS) and Quartz Crystal Microbalance Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: Italy 15-Year Perspective for Label-free Array Systems by Technology - Percentage Breakdown of Value Sales for Surface Plasmon Resonance (SPR), Bio-layer Interferometry (BLI), Cellular Dielectric Spectroscopy (CDS) and Quartz Crystal Microbalance for the Years 2015, 2025 & 2030
    • TABLE 110: Italy Recent Past, Current & Future Analysis for Label-free Array Systems by Application - Drug Discovery, Antibody Characterization and Development, Protein Interface Analysis and Protein Complex and Cascade Analysis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Italy Historic Review for Label-free Array Systems by Application - Drug Discovery, Antibody Characterization and Development, Protein Interface Analysis and Protein Complex and Cascade Analysis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: Italy 15-Year Perspective for Label-free Array Systems by Application - Percentage Breakdown of Value Sales for Drug Discovery, Antibody Characterization and Development, Protein Interface Analysis and Protein Complex and Cascade Analysis for the Years 2015, 2025 & 2030
    • TABLE 113: Italy Recent Past, Current & Future Analysis for Label-free Array Systems by End-Use - R&D Laboratories, Contract Research Organizations (CROs), Agriculture Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Italy Historic Review for Label-free Array Systems by End-Use - R&D Laboratories, Contract Research Organizations (CROs), Agriculture Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: Italy 15-Year Perspective for Label-free Array Systems by End-Use - Percentage Breakdown of Value Sales for R&D Laboratories, Contract Research Organizations (CROs), Agriculture Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Label-free Array Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 116: UK Recent Past, Current & Future Analysis for Label-free Array Systems by Technology - Surface Plasmon Resonance (SPR), Bio-layer Interferometry (BLI), Cellular Dielectric Spectroscopy (CDS) and Quartz Crystal Microbalance - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: UK Historic Review for Label-free Array Systems by Technology - Surface Plasmon Resonance (SPR), Bio-layer Interferometry (BLI), Cellular Dielectric Spectroscopy (CDS) and Quartz Crystal Microbalance Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: UK 15-Year Perspective for Label-free Array Systems by Technology - Percentage Breakdown of Value Sales for Surface Plasmon Resonance (SPR), Bio-layer Interferometry (BLI), Cellular Dielectric Spectroscopy (CDS) and Quartz Crystal Microbalance for the Years 2015, 2025 & 2030
    • TABLE 119: UK Recent Past, Current & Future Analysis for Label-free Array Systems by Application - Drug Discovery, Antibody Characterization and Development, Protein Interface Analysis and Protein Complex and Cascade Analysis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: UK Historic Review for Label-free Array Systems by Application - Drug Discovery, Antibody Characterization and Development, Protein Interface Analysis and Protein Complex and Cascade Analysis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: UK 15-Year Perspective for Label-free Array Systems by Application - Percentage Breakdown of Value Sales for Drug Discovery, Antibody Characterization and Development, Protein Interface Analysis and Protein Complex and Cascade Analysis for the Years 2015, 2025 & 2030
    • TABLE 122: UK Recent Past, Current & Future Analysis for Label-free Array Systems by End-Use - R&D Laboratories, Contract Research Organizations (CROs), Agriculture Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: UK Historic Review for Label-free Array Systems by End-Use - R&D Laboratories, Contract Research Organizations (CROs), Agriculture Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: UK 15-Year Perspective for Label-free Array Systems by End-Use - Percentage Breakdown of Value Sales for R&D Laboratories, Contract Research Organizations (CROs), Agriculture Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 125: Rest of Europe Recent Past, Current & Future Analysis for Label-free Array Systems by Technology - Surface Plasmon Resonance (SPR), Bio-layer Interferometry (BLI), Cellular Dielectric Spectroscopy (CDS) and Quartz Crystal Microbalance - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Rest of Europe Historic Review for Label-free Array Systems by Technology - Surface Plasmon Resonance (SPR), Bio-layer Interferometry (BLI), Cellular Dielectric Spectroscopy (CDS) and Quartz Crystal Microbalance Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: Rest of Europe 15-Year Perspective for Label-free Array Systems by Technology - Percentage Breakdown of Value Sales for Surface Plasmon Resonance (SPR), Bio-layer Interferometry (BLI), Cellular Dielectric Spectroscopy (CDS) and Quartz Crystal Microbalance for the Years 2015, 2025 & 2030
    • TABLE 128: Rest of Europe Recent Past, Current & Future Analysis for Label-free Array Systems by Application - Drug Discovery, Antibody Characterization and Development, Protein Interface Analysis and Protein Complex and Cascade Analysis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of Europe Historic Review for Label-free Array Systems by Application - Drug Discovery, Antibody Characterization and Development, Protein Interface Analysis and Protein Complex and Cascade Analysis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: Rest of Europe 15-Year Perspective for Label-free Array Systems by Application - Percentage Breakdown of Value Sales for Drug Discovery, Antibody Characterization and Development, Protein Interface Analysis and Protein Complex and Cascade Analysis for the Years 2015, 2025 & 2030
    • TABLE 131: Rest of Europe Recent Past, Current & Future Analysis for Label-free Array Systems by End-Use - R&D Laboratories, Contract Research Organizations (CROs), Agriculture Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Rest of Europe Historic Review for Label-free Array Systems by End-Use - R&D Laboratories, Contract Research Organizations (CROs), Agriculture Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: Rest of Europe 15-Year Perspective for Label-free Array Systems by End-Use - Percentage Breakdown of Value Sales for R&D Laboratories, Contract Research Organizations (CROs), Agriculture Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Label-free Array Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 134: Asia-Pacific Recent Past, Current & Future Analysis for Label-free Array Systems by Technology - Surface Plasmon Resonance (SPR), Bio-layer Interferometry (BLI), Cellular Dielectric Spectroscopy (CDS) and Quartz Crystal Microbalance - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Asia-Pacific Historic Review for Label-free Array Systems by Technology - Surface Plasmon Resonance (SPR), Bio-layer Interferometry (BLI), Cellular Dielectric Spectroscopy (CDS) and Quartz Crystal Microbalance Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: Asia-Pacific 15-Year Perspective for Label-free Array Systems by Technology - Percentage Breakdown of Value Sales for Surface Plasmon Resonance (SPR), Bio-layer Interferometry (BLI), Cellular Dielectric Spectroscopy (CDS) and Quartz Crystal Microbalance for the Years 2015, 2025 & 2030
    • TABLE 137: Asia-Pacific Recent Past, Current & Future Analysis for Label-free Array Systems by Application - Drug Discovery, Antibody Characterization and Development, Protein Interface Analysis and Protein Complex and Cascade Analysis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Asia-Pacific Historic Review for Label-free Array Systems by Application - Drug Discovery, Antibody Characterization and Development, Protein Interface Analysis and Protein Complex and Cascade Analysis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: Asia-Pacific 15-Year Perspective for Label-free Array Systems by Application - Percentage Breakdown of Value Sales for Drug Discovery, Antibody Characterization and Development, Protein Interface Analysis and Protein Complex and Cascade Analysis for the Years 2015, 2025 & 2030
    • TABLE 140: Asia-Pacific Recent Past, Current & Future Analysis for Label-free Array Systems by End-Use - R&D Laboratories, Contract Research Organizations (CROs), Agriculture Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Asia-Pacific Historic Review for Label-free Array Systems by End-Use - R&D Laboratories, Contract Research Organizations (CROs), Agriculture Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: Asia-Pacific 15-Year Perspective for Label-free Array Systems by End-Use - Percentage Breakdown of Value Sales for R&D Laboratories, Contract Research Organizations (CROs), Agriculture Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF WORLD
    • TABLE 143: Rest of World Recent Past, Current & Future Analysis for Label-free Array Systems by Technology - Surface Plasmon Resonance (SPR), Bio-layer Interferometry (BLI), Cellular Dielectric Spectroscopy (CDS) and Quartz Crystal Microbalance - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Rest of World Historic Review for Label-free Array Systems by Technology - Surface Plasmon Resonance (SPR), Bio-layer Interferometry (BLI), Cellular Dielectric Spectroscopy (CDS) and Quartz Crystal Microbalance Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: Rest of World 15-Year Perspective for Label-free Array Systems by Technology - Percentage Breakdown of Value Sales for Surface Plasmon Resonance (SPR), Bio-layer Interferometry (BLI), Cellular Dielectric Spectroscopy (CDS) and Quartz Crystal Microbalance for the Years 2015, 2025 & 2030
    • TABLE 146: Rest of World Recent Past, Current & Future Analysis for Label-free Array Systems by Application - Drug Discovery, Antibody Characterization and Development, Protein Interface Analysis and Protein Complex and Cascade Analysis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Rest of World Historic Review for Label-free Array Systems by Application - Drug Discovery, Antibody Characterization and Development, Protein Interface Analysis and Protein Complex and Cascade Analysis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: Rest of World 15-Year Perspective for Label-free Array Systems by Application - Percentage Breakdown of Value Sales for Drug Discovery, Antibody Characterization and Development, Protein Interface Analysis and Protein Complex and Cascade Analysis for the Years 2015, 2025 & 2030
    • TABLE 149: Rest of World Recent Past, Current & Future Analysis for Label-free Array Systems by End-Use - R&D Laboratories, Contract Research Organizations (CROs), Agriculture Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Rest of World Historic Review for Label-free Array Systems by End-Use - R&D Laboratories, Contract Research Organizations (CROs), Agriculture Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 151: Rest of World 15-Year Perspective for Label-free Array Systems by End-Use - Percentage Breakdown of Value Sales for R&D Laboratories, Contract Research Organizations (CROs), Agriculture Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030

IV. COMPETITION

비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제